Waters, Kraus & Paul
El Segundo, California OfficeView all offices
222 N. Sepulveda Blvd., Suite 1900
El Segundo, California
(Los Angeles Co.)
Toll Free: 800.226.9880 Telecopier: 310.414.8156
|Profile Visibility |
|#11 in weekly profile views out of 81 law firms in El Segundo, California|
|#108 in weekly profile views out of 281,584 total law firms Overall|
Office Hours:Monday: 08:00 AM-05:00 PM
Tuesday: 08:00 AM-05:00 PM
Wednesday: 08:00 AM-05:00 PM
Thursday: 08:00 AM-05:00 PM
Friday: 08:00 AM-05:00 PM
About this office:
Waters & Kraus, LLP is a mid-sized plaintiffs' firm with a successful national practice, as well as international experience. Our attorneys focus on toxic tort litigation (asbestos/mesothelioma), consumer product liability, as well as qui tam (whistleblower) and commercial litigation. With offices in California and Texas, Waters & Kraus, LLP has litigated cases in jurisdictions across the United States on behalf of individuals from all 50 states, as well as foreign governments. To learn more about the firm and our practice, please go to www.waterskrauspaul.com.
Specific Practice & Industry Groups Details:
Statement of Practice Summary:
Mesothelioma; Asbestos Cancer; Civil Law; Class Actions; Qui Tam; Pharmaceutical; Product Liability; Toxic Torts; Asbestos Litigation; Whistleblower Litigation; International Litigation; Drug and Medical Device Litigation; Dental Medicaid Fraud; Medicare Fraud and Abuse; Birth and Childhood Injury.
Documents by Lawyers at this office
Seattle Cancer Center Using New SMART Mesothelioma Treatment
David Bricker,Gary M. Paul, August 7, 2015
A Seattle mesothelioma treatment center is now using the Surgery for Mesothelioma After Radiation Therapy (SMART) methodology developed by doctors at the Princess Margaret Cancer Center in Toronto. In Canada, where the SMART protocol has been studied previously, the percentage of mesothelioma...
California Mesothelioma Doctors Studying Cryoablation
Shawna Forbes-King,Michael B. Gurien, July 14, 2015
Mesothelioma specialists at the Pacific Mesothelioma Center (PMC), David Geffen School of Medicine UCLA, have long been advocates for using cryoablation to treat mesothelioma tumors that return following surgery. Now PMC researchers reportedly are looking for ways to boost the effectiveness of...
CRS-207 Receives Orphan Drug Status for Mesothelioma
Michael B. Gurien,Michael B. Gurien,Gary M. Paul,Gary M. Paul, April 22, 2015
CRS-207 has been granted orphan drug status by the U. S. Food and Drug Administration (FDA) for treatment of pleural mesothelioma patients. CRS-207, manufactured by Aduro Biotech, had previously been granted orphan drug designation for treatment of pancreatic cancer. The orphan drug designation is...
Year Established: 1995
Languages: English and Spanish.